The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges

The introduction of immune checkpoint inhibitors has constituted a major revolution in the treatment of patients with cancer. In contrast with the traditional cytotoxic therapies that directly kill tumor cells, this treatment modality enhances the ability of the host’s immune system to recognize and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouferraa, Youssef, Chedid, Andrea, Amhaz, Ghid, El Lakkiss, Ahmed, Mukherji, Deborah, Temraz, Sally, Shamseddine, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347208/
https://www.ncbi.nlm.nih.gov/pubmed/34360802
http://dx.doi.org/10.3390/ijms22158036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347208/
https://www.ncbi.nlm.nih.gov/pubmed/34360802
http://dx.doi.org/10.3390/ijms22158036

Ejemplares similares